The September Small Doses brings you the latest news that affects pharmacists.
Stalled competition hurts consumers and may keep prices higher.
Drug Topics recently spoke with the FDA about the role pharmacists can play in patient education.
The EpiPen shortage is putting lives at risk and creating a back-up at some pharmacies. But solutions are on the horizon.
An unclear naming system for biosimilars could affect patient safety.
The drug is the first approved under the agency's new, quicker generic approval designation.
The agency is exploring ways to increase vital medication access.
FDA releases Biosimilar Action Plan
What you need to know about the latest FDA approval.
Brand-name drug companies are finding creative ways to extend patent protection, causing patient access problems.